366 related articles for article (PubMed ID: 16359827)
1. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
Wynter CV
Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
Teodoridis JM; Strathdee G; Brown R
Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
4. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Clark SJ
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
6. RNA interference--significance and applications.
Stanisławska J; Olszewski WL
Arch Immunol Ther Exp (Warsz); 2005; 53(1):39-46. PubMed ID: 15761375
[TBL] [Abstract][Full Text] [Related]
7. [Great potential of small RNAs: RNA interference and microRNA].
Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
9. Short interfering RNAs as a tool for cancer gene therapy.
Izquierdo M
Cancer Gene Ther; 2005 Mar; 12(3):217-27. PubMed ID: 15550938
[TBL] [Abstract][Full Text] [Related]
10. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
Mook OR; Baas F; de Wissel MB; Fluiter K
Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
[TBL] [Abstract][Full Text] [Related]
11. De novo DNA methylation induced by siRNA targeted to endogenous transcribed sequences is gene-specific and OsMet1-independent in rice.
Miki D; Shimamoto K
Plant J; 2008 Nov; 56(4):539-49. PubMed ID: 18643988
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
Niu J; Xu Z; Li XN; Han Z
Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
[TBL] [Abstract][Full Text] [Related]
14. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
Lopez-Serra L; Ballestar E; Ropero S; Setien F; Billard LM; Fraga MF; Lopez-Nieva P; Alaminos M; Guerrero D; Dante R; Esteller M
Oncogene; 2008 Jun; 27(25):3556-66. PubMed ID: 18223687
[TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated pathways in the nucleus.
Matzke MA; Birchler JA
Nat Rev Genet; 2005 Jan; 6(1):24-35. PubMed ID: 15630419
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional gene silencing by short interfering RNAs.
Kawasaki H; Taira K
Curr Opin Mol Ther; 2005 Apr; 7(2):125-31. PubMed ID: 15844619
[TBL] [Abstract][Full Text] [Related]
17. Aberrant gene silencing in tumor progression: implications for control of cancer.
Baylin SB; Chen WY
Cold Spring Harb Symp Quant Biol; 2005; 70():427-33. PubMed ID: 16869780
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes in cancer and preneoplasia.
Herman JG
Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769
[TBL] [Abstract][Full Text] [Related]
19. RNA-interference-directed chromatin modification coupled to RNA polymerase II transcription.
Schramke V; Sheedy DM; Denli AM; Bonila C; Ekwall K; Hannon GJ; Allshire RC
Nature; 2005 Jun; 435(7046):1275-9. PubMed ID: 15965464
[TBL] [Abstract][Full Text] [Related]
20. Molecular therapy in the microRNA era.
Wurdinger T; Costa FF
Pharmacogenomics J; 2007 Oct; 7(5):297-304. PubMed ID: 17189960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
